Oura is acquiring medical AI chatbot startup Counsel Health

Oura announced its quarterly earnings today and stated it accepted to acquire Counsel Health for $625 million, following adding the company’s AI chatbot to its app earlier this year. Counsel Health calls itself an “AI-native chief attention company,” using the app to provision AI-generated responses and insights according to users’ health data reported from their wearables that can afterward continue to a conversation alongside one of its in-house physicians.

Oura says it expects the agreement to near before the end of the year.

Oura CEO Tom Hale stated in an discussion alongside Bloomberg that the acquisition is part of a scheme to nexus wearables, medicinal AI, and admission to doctors according to insights from biometric data to answer questions or detect ongoing conditions. Counsel Health’s AI chatbot can nexus Oura users to a genuine doctor immediately from the app and diagram on users’ biometric data from their wearables in its answers to medicinal questions. The scheme they depict in the media publish is to concentration on three areas, including preventative care, acute attention for episodic health concerns, and specialty and chronic attention for things akin reproductive and cardiometabolic health.

According to Bloomberg, Counsel Health’s CEO Muthu Alagappan says it’s additionally preparedness to develop its network of on-demand physicians, which is currently “made up of concerning 50 people.” Counsel’s 70 workforce volition associate Oura as part of the deal, alongside Alagappan becoming Oura’s chief medicinal AI officer. Oura says in its notice that Counsel volition additionally continue offering its medicinal AI phase exterior of Oura’s person basis through new and existing endeavor partners, including “health plans, health systems, person health organizations, and employers.”